Open AccessPeer ReviewedPublished Monthly Since 2007 Vol. 19, Issue 12 · November 2026Media Kitinfo@guident.net

Prophylactic Antibiotic Regimen for Elective Dental Procedures to Prevent Subacute Bacterial Endocarditis

  • Dr. Vinay MohanProfessor & Head
  • Dr. Kushdeep Kumar GuptaP.G Student
  • Dr. Anumita DekaP.G. Student

Department of Oral Medicine and Radiology, K.D. Dental College and Hospital, Mathura India

Guident · Volume 16, Issue 10 (September 2023)Published September 20237 min read

ABSTRACT

In dental invasive procedures use of antibiotic prophylaxis to prevent Infective endocarditis. Infective endocarditis (IE) is a rare condition, with high morbidity and mortality. With an older population and increasing use of implant cardiac devices and heart valves, the epidemiology of IE has changed. Early clinical suspicion and a rapid diagnosis are essential to treatment and to reduce complication and mortality rates.

Keywords: Infective endocarditis, antibiotic prophylaxis, diagnosis

INTRODUCTION

Infective endocarditis. IE, also known as acute or subacute bacterial endocarditis, is defined as an exudative and proliferative inflammatory alteration of the endocardium; it is characterized by vegetations on the surface or within the endocardium that are caused by an infection with microorganisms. A heart valve is commonly involved and proliferation also may occur in the inner lining of the cardiac chambers.1,2 It is well-recognized that IE arises from the colonization of a preexisting lesion, usually composed of fibrin and platelets, that develops from the disruption of the endothelial lining via abnormal development, disease or presence of foreign bodies and turbulent blood flow. This accumulation of fibrin, blood products and platelets, known as nonbacterial thrombotic endocarditis, or NBTE, adheres to the damaged endothelium. The endothelium is later colonized by bacteria, which, in turn, stimulates further platelet aggregation and the bacteria become incorporated into the vegetations of the lesion.

ENDOCARDITIS PROPHYLAXIS FOR DENTAL PROCEDURES

Good oral hygiene is probably the most important factor in reducing the risk of endocarditis in susceptible individuals, and access to high-quality dental care should be facilitated. Once a patient is found to have a cardiac anomaly putting him or her at a risk of endocarditis, the patient should be referred to have their dental hygiene optimized. Similarly, a patient who has received an intracardiac prosthesis (valve, conduit, aortic graft) should be referred for dental assessment. Interventions ideally should be performed at least 14 days prior to surgery to allow mucosal healing. Those patients who undergo urgent or emergency valve replacement should have a dental assessment performed as soon as practicable after surgery, and a risk assessment performed to determine the most appropriate plan for any remedial dental treatment. All elective dental procedures should ideally be delayed for at least 3 months postsurgery.

Endocarditis prophylaxis for dental procedures

Dental extractions

Periodontal procedures, including surgery, scaling, root planing, probing periodontal pockets and recall maintenance

Dental implant placement and reimplantation of avulsed teeth

Endodontic (root canal) instrumentation or surgery beyond the apex

Subgingival placement of antibiotic fibres or strips

Initial placement of orthodontic bands, but not brackets

Intraligamentary local anaesthetic injections

Prophylactic cleaning of teeth or implants where bleeding is anticipated

Incision and drainage or other procedures involving infected tissues

ENDOCARDITIS PROPHYLAXIS FOR NON-DENTAL PROCEDURES

The same cannot be applied to bacteremia-inducing, non-dental procedures undertaken in patients who are at risk of developing endocarditis. Indeed, it is likely that the pathogenesis of endocarditis differs between the oral streptococci and other pathogens, such as enterococci, until more information becomes available. The risk of endocarditis associated with various procedures can be inferred from two equally unsatisfactory sources:

(i) the chance of a procedure causing bacteremia and thus seeding an 'at-risk' cardiac lesion and

(ii) whether such a procedure has been anecdotally linked to cases of endocarditis.

Endocarditis prophylaxis for non-dental procedures

Cystoscopy

Urethral catheterization/dilatation

Vasectomy

Lithotripsy of renal stones

Cosmetic piercing involving urethral mucosa

Vaginal hysterectomy

Therapeutic abortion

INITIAL GUIDELINES ON THE USE OF ANTIBIOTIC PROPHYLAXIS TO PREVENT IE

The first AHA guidelines identified those with rheumatic or congenital heart disease as being at increased risk of IE, and “dental extraction and other dental manipulations which disturb the gums, the removal of tonsils and adenoids, the delivery of pregnant women, and operations on the gastrointestinal or urinary tracts” as procedures where AP was indicated. They recommended intramuscular penicillin (600,000 units of aqueous penicillin or 500,000 units of procaine penicillin in oil containing 2% aluminium monostearate) 30 min before dental procedures. An alternative, but less desirable, oral penicillin regimen was also described (250,000–500,000 units “one-half hour before each meal and at bedtime, beginning twenty-four hours prior to the operation and continuing for 5 days”, an extra dose of 250,000 units being desirable at the time of the procedure).

However, the emergence of valve replacement surgery during the 1960s and 1970s11-14 brought recognition that these patients were at particularly high-risk of IE. Importantly, the possibility that bacteraemia with oral organisms could occur in the absence of dental procedures and the consequent need to “maintain the highest level of oral health” were recognised for the first time.

SINGLE ORAL DOSE ANTIBIOTIC PROPHYLAXIS REGIMENS

A single 3g oral dose of amoxicillin 1 hour before the procedure was recommended on the grounds of effectiveness and improved compliance. Furthermore, the same protocol was recommended for all patients at increased risk of IE, including those with prosthetic valves. Parenteral antibiotic regimens were only recommended for those undergoing a general anaesthetic. Subsequent AHA and ESC guidelines moved towards wider adoption of simple oral AP regimens and the adoption of clindamycin in preference to erythromycin for those allergic to penicillin.

For the first time, the AHA guidelines recommended a single 2 g oral dose of amoxicillin as the preferred AP regimen for all patients at risk of IE undergoing dental, oral, respiratory tract or oesophageal procedures, with clindamycin 600 mg as a single oral dose 1 h before the procedure for those allergic to penicillin. These guidelines were broadly matched by the 2004 European Society of Cardiology (ESC) guidelines.15

Standard Regimens for Antibiotic Prophylaxis to Monimize Risk of Bacterial Endocarditis after Oral Procedures4

Patient Cateogary

Oral Medications

Non-Oral Medications

Adults, not allergic to penicillin

2.0g amoxicillin 1 h before procedure

2.0g ampicillin IM or IV within 30 min before procedure

Adults, penicillin allergic

600 mg clindamycin 1 h before procedure or 2.0 g cephalexin 1 hr before procedure or 500 mg azithromycin or clarithromycin 1 h before procedure

600 mg clindamycin IV within 30 min before procedure or 1.0 g cefazolin IM or IV within 30 min before procedure

Chlidren , not allergic to penicillin

50 mg/kg amoxicillin 1 h before procedure

50 mg/kg ampicillin IM or IV within 30 min before procedure

Children, penicillin allergic

20 mg/kg clindamycin 1 h before procedure or

50 mg/kg cephalexin or cefadroxil 1 h before procedure or

15 mg/kg azithromycin or clarithromycin 1 h before procedure

20 mg/kg IV clindamycin within 30 min prior to procedure or

25 mg/kg IM or IV cefazolin 30 min before procedure

CONCLUSION

AHA recommendations that restrict infective endocarditis prevention to the highest risk cardiac patients scheduled for dental operations. To increase the rate of prophylaxis recommended compliance, effort should be concentrated on the group at the greatest risk. All patients should have their oral and general hygiene practices emphasized, as well as routine preventative dental examinations. Before prescribing antibiotics in the presence of fever, infective endocarditis should be ruled out. Patients should be informed of this fact and given an explanation of why the infective endocarditis preventive strategy was changed. A more thorough examination of factors linked to a higher risk of dying from infective endocarditis or an increased chance of developing infective endocarditis from certain medical and surgical conditions including staphylococcus bacteremia.

REFERENCES

  1. Taylor E, ed. Dorland’s illustrated medical dictionary. 27th ed. Philadelphia: Saunders; 1988:552.
  2. Yagiela J. Prophylactic antibiotics: cardiac and prosthetic considerations. J Calif Dent Assoc 1995;23:29-40.
  3. Seymour RA, Lowry R, Whitworth JM, Martin MV. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink? Br Dent J. 2000 Dec 9;189(11):610-6.
  4. Burket’s Oral Medicine Diagnosis and Treatment 10th edition.
  5. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ et.al Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.
  6. Lewis T, Grant R. Observations relating to subacute infective endocarditis. Heart. 1923;10:21–77.
  7. Okell CC, Elliott SD. Bacteraemia and oral sepsis: with special reference to the aetiologu of subacute endocarditis. Lancet. 1935;226:869–72.
  8. Billings F. Mouth infection as a source of systemic disease. JAMA. 1914;LXIII:899–903.
  9. Billings F. The principles involved in focal infection as related to systemic disease. JAMA. 1916;LXVii:847–50.
  10. Focal infection. J Am Med Assoc. 1952;150:490–1.
  11. Carpentier A. The concept of bioprosthesis. Thoraxchir Vask Chir. 1971;19:379–83.
  12. Harken DE, Taylor WJ, Lefemine AA, Lunzer S, Low HB, Cohen ML, et al. Aortic valve replacement with a caged ball valve. Am J Cardiol. 1962;9:292–9.
  13. Ross DN. Homograft replacement of the aortic valve. Lancet. 1962;2:487.
  14. Starr A, Edwards ML. Mitral replacement: clinical experience with a ball-valve prosthesis. Ann Surg. 1961;154:726–40.
  15. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J. 2004;25: 267–76
  16. Gould FK, Elliott TS, Foweraker J, Fulford M, Perry JD, Roberts GJ, Sandoe JA, Watkin RW; Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2006 Jun;57(6):1035-42.

Disclaimer from Guident

The views and opinions expressed in articles published in Guident are solely those of the authors and do not necessarily reflect the views of the editors, the editorial board or the publisher, Ivory India. Guident does not endorse any product, technique or treatment described. Clinical content is intended for qualified dental and medical professionals and is not a substitute for individual clinical judgement. Guident, its editors and the publisher accept no liability for any consequence arising from the use of information published in the journal.

How to cite this article

Dr. Vinay Mohan, Dr. Kushdeep Kumar Gupta, Dr. Anumita Deka. Prophylactic Antibiotic Regimen for Elective Dental Procedures to Prevent Subacute Bacterial Endocarditis. Guident. 2023 Sep;16(10). Available from: https://ivoryindia.in/articles/oral-medicine/prophylactic-antibiotic-regimen-for-elective-dental-procedures-to-prevent-subacute-bacterial-endocarditis.html

Related articles

More in Oral Medicine

All 48 articles
Vol. 16, Issue 10 · September 2023

Benign Fibro-Epithelial Polyp: A Case Report

The most typical epithelial benign tumour of the oral cavity is a fibro-epithelial polyp. Such a polyp is a sessile or pedunculated growth that resembles a pink, red, or white knob and is…

Dr. Sameeksha Bhardwaj

Vol. 16, Issue 9 · August 2023

Peripheral Ossifying Fibroma: A Case Report

Peripheral ossifying fibroma (POF) is a localized reactive rather than neoplastic enlargement exclusively on the gingiva. POF has females predominance with site predilection of anterior…

Dr. Nirmala Khanal

Call for papers

Publish your clinical work in Guident

Original research, case reports and review articles are welcomed from clinicians and researchers worldwide. Every submission is assessed by the editorial board.